Skip to main content
Fig. 4 | BMC Medical Genomics

Fig. 4

From: Integrated single-cell and bulk RNA sequencing analysis identifies a neoadjuvant chemotherapy-related gene signature for predicting survival and therapy in breast cancer

Fig. 4

Clinicopathological significance of NAC response-related risk score in clinical variables.A: Differences in NAC response-related risk scores between age group; B: Differences in NAC response-related risk scores across different tumor grade; C: Differences in NAC response-related risk scores within different TNM stage; D: Differences in NAC response-related risk scores in different intrinsic subtypes; E: Differences in NAC response-related risk scores across ER status; F: Differences in NAC response-related risk scores across PR status; G: Differences in NAC response-related risk scores across HER2 status; H: Univariate cox analysis of risk score in the GSE25055 cohort; I: Multivariate cox analysis of risk score in the GSE25055 cohort; J: K-M curve of NAC prognosis model in different groups of age

Back to article page